Clinical Solutions
Heart disease is often silent yet deadly. Our innovative clinical solutions can offer more precise and actionable insights, defining a new standard in precision cardiovascular care.
Transcending Traditional Proxy Markers
Cardio Diagnostics' solutions characterize heart disease at the molecular level and do not rely on merely proxy markers such as cholesterol, symptoms such as chest pain or the narrow focus of stenosis. Rather, our solutions use the lens of AI to uncover the epigenetic and genetic molecular underpinnings that may precede symptoms and measurable physical changes. With advanced insights based on actual disease and not indirect markers of disease, we enable a more personalized approach to advanced cardiovascular care where each patient is treated as a category of one for the purpose of assessing heart attack risk, detecting coronary heart disease, and managing it.
State-of-the-Art Solutions for Coronary Heart Disease
Cardio Diagnostics offers three AI-powered solutions for the risk assessment, detection, management and monitoring of coronary
heart disease, the most common type of heart disease and the primary cause of heart attacks.
|
|
3-year coronary heart disease event (heart attack, sudden death from CHD) risk assessment |
Detection and management of coronary heart disease |
Powered by our proprietary digital PCR assays and FormaAI algorithm |
Powered by our proprietary digital PCR assays and SapiensAI algorithm |
76% sensitive for males and 78% sensitive for females |
80% sensitive for males and 76% sensitive for females |
CPT PLA code: 0439U |
CPT PLA code: 0440U |
Rx Only |
Rx Only |
|
A provider-facing platform available for the PrecisionCHD™ test that delivers personalized insights by linking the epigenetic and genetic biomarkers evaluated by the test to the drivers of coronary heart disease.
Chronic care management
|
Disease pathways |
Monitor effectiveness of treatment |
Order Now
Democratizing Access
to Advanced AI-Driven Cardiovascular Care
Cardio Diagnostics’ solutions are designed for scalability and access, addressing the critical needs of underserved populations in cardiology deserts, rural areas, and regions worldwide affected by healthcare disparities.
Percentage of rural counties in the US without a cardiologist
Average round trip distance to nearest cardiologist in counties without cardiologists
Percentage of higher cardiovascular risk index in counties without a cardiologist
Percentage of cardiovascular disease deaths occurring in low- and middle-income countries
We are tackling these challenges through our innovative, AI-driven solutions that are flexible, scalable and improve access to cardiovascular care along three dimensions.
Our solutions, such as Epi+Gen CHD and PrecisionCHD, only require a simple blood draw that can be performed in various settings, from rural clinics to urban hospitals. These tests are designed to be highly scalable, requiring minimal infrastructure and no specialized cardiology equipment. Mobility-challenged patients and those seeking convenience can collect their blood sample at home.
Our solutions are designed for flexibility in clinical use, allowing them to be prescribed by primary care clinicians or cardiologists without needing interpretation by an on-site specialist. This accessibility ensures that patients can receive advanced cardiovascular testing regardless of their immediate access to specialized cardiology services.
Our solutions integrate seamlessly with telemedicine platforms, allowing for remote consultation and follow-up care. This extends the reach of specialized cardiovascular care and bridges access to advanced technologies for underserved and rural communities.